Breast cancer drug may throw patients off balance, study finds

NCT ID NCT06184074

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 76 postmenopausal women with breast cancer to see if aromatase inhibitors affect balance and fall risk. Half the women had been taking the drug for at least a year, the other half never took it. Researchers measured balance using special tests and questionnaires. The goal is to understand if these common drugs increase the chance of falling.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

aromatase inhibitors

What this could lead to

If this study finds clear links, it could help doctors monitor balance issues in breast cancer patients on aromatase inhibitors and possibly reduce fall risk.

What could go wrong

This is a small, completed observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ece Küçük

    Istanbul, 34457, Turkey (Türkiye)